Clinical trial
The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and…
NCT00401310 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00401310 |
|---|---|
| Title | The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018) |
| Official title | A Phase IIa Randomized, Double-Blind, Parallel-Groups, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of MK0724 Intravenous Infusion on the Amelioration of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Middle Cerebral Artery Stroke |
| Intervention type | Drug |
| Interventions | Comparator: Placebo, Comparator: MK0724 |
| Enrollment | 150 |
| Start date | Jul 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Nov 20, 2006 |
| Last update posted | Jul 22, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: